Advanced search

The status of allopurinol in the management of tumor lysis syndrome: a clinical review.

Fredrick Hagemeister, Auris Huen

Journal: Cancer journal (Sudbury, Mass.) 2005;11 Suppl 1():S1-10

PMID: 15835720

View on PubMed

Abstract

Address: Department of Lymphoma, MD Anderson Cancer Center, Houston, Texas, USA. [email protected]
MeSH Terms: Allopurinol, Antimetabolites, Humans, Hyperkalemia, Hyperuricemia, Infusions, Intravenous, Phosphates, Risk Factors, Tumor Lysis Syndrome, Urate Oxidase
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

Sponsor Sponsor Sponsor Sponsor Sponsor Sponsor Sponsor

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.